Author archives: Taj Life

The Controversy Over Chloroquine for COVID-19

The Controversy Over Chloroquine for COVID-19
An old drug is getting new attention, but is it for the right reasons? In regular press briefings on COVID-19, President Trump and members of his administration have repeatedly touted a potential treatment: hydroxychloroquine. On Twitter the president described it as potentially ?one of the biggest game changers in the history of medicine.? However Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) and prominent member of the coronavirus task force, has tried to temper enthusiasm for the therapeutic regimen, citing a lack of evidence. So what?s driving the hype around this old drug, and is it deserved?

Letter from Taj Pharma CEO and Leadership Team COVID-19

Letter from Taj Pharma CEO and Leadership Team COVID-19
At Taj Pharmaceuticals, we are working on using this challenge as an opportunity to make our company more dedicated, more efficient, and more focused on serving the needs of our clients, a better company to partner with in our common mission of bringing healthcare treatments to market faster and of improving outcomes for patients. COVID-19, Taj Pharma?CEO, Generics Supply, COVID-19 trials, COVID-19 treatments Generics Supply Centers, COVID-19 clinical trials, coronavirus ongoing trials